One year Outcome of Combined Phacoemulsification and Endoscopic Cyclophotocoagulation vs. Phacoemulsification Alone in Patients with Primary Glaucoma: The Malaysian experience.

Abstract

Title

One year Outcome of Combined Phacoemulsification and Endoscopic Cyclophotocoagulation vs. Phacoemulsification Alone in Patients with Primary Glaucoma: The Malaysian experience.

Background

To compare the post-operative outcomes phaco-ECP with phaco alone in patients with primary glaucoma in terms of efficacy and safety.

Methods

Retrospective comparison case series of all patients undergoing phaco and phaco-ECP were done. Inclusion criteria were all eyes with primary glaucoma and at least on 2 antiglaucoma medications who underwent phaco-ECP and phaco alone. Mean IOP and number of topical antiglaucoma medications were assessed at 1 week, 1 months, 3 months, 6 months, and 1 year post-operatively.

Results

A number of 18 eyes from each group were recruited into the study (N=36). In phaco-ECP group, mean IOP reduction were seen at 1 week (p=0.021), 1 month (p=0.009), 3 months (p=0.034), and 6 months (p=0.0.34), but increased at 1 year post-operation (p=0.775). Phaco group showed either statistically non-significant reduction or increment of mean IOP throughout the study period. For mean number of topical antiglaucoma medication used, significant reduction were seen in the phaco-ECP group at each intervals (1 week; p=0.004, 1 month; p=0.001, 3 months; p=0.000, 6 months; p=0.002, 1 year; p=0.035), unlike the phaco group which showed no changes.

Conclusion

Significant reduction of IOP in the first 6 months post phaco-ECP was seen, as well as elimination of 1 topical antiglaucoma medication in this group during the first year of post-operation.

Conflict of Interest

There is no conflicting relationship exists for any author.

Key words:

ECP, phacoemulsification